Experience

Specific Diagnostics

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Scientist

  • Jan 2023 - Present



List Biological Laboratories, Inc.

• United States
• Biotechnology Research
• 1 - 100 Employee

• QC Specialist III

  • May 2021 - Jan 2023



DURECT Corporation

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Quality Control Microbiologist II

  • Apr 2019 - May 2021

  Grow promotion in media, bioburden testing, Endotoxin detection in water and finished product, environment monitoring in manufacturing areas, writing, revising and validating SOPs. Grow promotion in media, bioburden testing, Endotoxin detection in water and finished product, environment monitoring in manufacturing areas, writing, revising and validating SOPs.



Novartis Science

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Scientist II

  • Oct 2011 - Sep 2018

  I contributed to set up the microbiology laboratory in the Emeryville facility. I participated on the design and testing primary and secondary susceptibility evaluation of novel compounds, and was the lead microbiologist in the monobactam project that led to the discovery of LYS228, currently in phase I clinical trials. I co-wrote research data reports that supported IND filing of LYS228, as well as co-authored several pier-reviewed articles and posters. I trained and mentored junior associates from various project teams. Show less



Achaogen

• United States
• Biotechnology Research
• 1 - 100 Employee

• Sr Research Associate II

  • Jan 2006 - Oct 2011

  I set up the microbiology laboratory. I created and organized the internal clinical strain collection by the acquisition, cryopreservation and maintenance of corresponding data base. I designed and performed primary and secondary susceptibility evaluation of novel compounds by CLSI methods. I trained and mentored new hires. I was part of the aminoglycosides project team that lead to the discovery of plazomycin. I set up the microbiology laboratory. I created and organized the internal clinical strain collection by the acquisition, cryopreservation and maintenance of corresponding data base. I designed and performed primary and secondary susceptibility evaluation of novel compounds by CLSI methods. I trained and mentored new hires. I was part of the aminoglycosides project team that lead to the discovery of plazomycin.



Versicor/Vicuron

• Fremont

• Research Scientist III

  • Mar 1999 - Nov 2005

  I worked in bioprofiling of PDF inhibitors, lincosamides, oxazolidinones programs and co-wrote reports for IND filling. I Participated in the in vitro microbiological evaluation of clinical development candidates dalbavancin and anidulafungin. I worked in bioprofiling of PDF inhibitors, lincosamides, oxazolidinones programs and co-wrote reports for IND filling. I Participated in the in vitro microbiological evaluation of clinical development candidates dalbavancin and anidulafungin.



Celtrix Pharmaceuticals

• Santa Clara

• QC Associate

  • Feb 1996 - Sep 1997

  I performed QC evaluation as part of pharmaceutical production line operating under GMP, including environmental monitoring, USP water testing, bioburden, endotoxin testing and bacterial cultivation and identification. I also wrote, revised and validated standard operating procedures I performed QC evaluation as part of pharmaceutical production line operating under GMP, including environmental monitoring, USP water testing, bioburden, endotoxin testing and bacterial cultivation and identification. I also wrote, revised and validated standard operating procedures